» Authors » Fritz A Muhlschlegel

Fritz A Muhlschlegel

Explore the profile of Fritz A Muhlschlegel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 1079
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pentland D, Davis J, Muhlschlegel F, Gourlay C
NPJ Biofilms Microbiomes . 2021 Aug; 7(1):67. PMID: 34385462
C. albicans is the predominant human fungal pathogen and frequently colonises medical devices, such as voice prostheses, as a biofilm. It is a dimorphic yeast that can switch between yeast...
2.
Ribeiro C, Rahman L, Holmes L, Woody A, Webster C, Monaghan T, et al.
Arch Microbiol . 2021 Mar; 203(5):2541-2550. PMID: 33682076
The spread of multidrug-resistance in Gram-negative bacterial pathogens presents a major clinical challenge, and new approaches are required to combat these organisms. Nitric oxide (NO) is a well-known antimicrobial that...
3.
Pentland D, Piper-Brown E, Muhlschlegel F, Gourlay C
Microb Cell . 2018 Feb; 5(2):63-73. PMID: 29417055
The small GTPase Ras acts as a master regulator of growth, stress response and cell death in eukaryotic cells. The control of Ras activity is fundamental, as highlighted by the...
4.
Martin R, Pohlers S, Muhlschlegel F, Kurzai O
Curr Genet . 2017 May; 63(6):965-972. PMID: 28493119
Adaptation to the changing environmental CO levels is essential for all living cells. In particular, microorganisms colonizing and infecting the human body are exposed to highly variable concentrations, ranging from...
5.
Pohlers S, Martin R, Kruger T, Hellwig D, Hanel F, Kniemeyer O, et al.
mBio . 2017 Feb; 8(1). PMID: 28143980
Importance: All living organisms have to cope with alternating CO concentrations as CO levels range from very low in the atmosphere (0.04%) to high (5% and more) in other niches,...
6.
Chow V, Khan S, Balogun A, Mitchell D, Muhlschlegel F
Med Mycol Case Rep . 2015 Mar; 8:5-9. PMID: 25750854
Mucormycosis is a rare life threatening fungal infection predominately seen in immunocompromised or diabetic patients. The following case is of a known type II diabetic patient who presented with sepsis...
7.
Talpaert M, Balfour A, Stevens S, Baker M, Muhlschlegel F, Gourlay C
J Med Microbiol . 2014 Aug; 64(Pt 3):199-208. PMID: 25106862
Laryngopharyngeal malignancy is treated with radiotherapy and/or surgery. When total laryngectomy is required, major laryngeal functions (phonation, airway control, swallowing and coughing) are affected. The insertion of a silicone rubber...
8.
Hess K, Liu J, Manfredi G, Muhlschlegel F, Buck J, Levin L, et al.
FASEB J . 2014 Jul; 28(10):4369-80. PMID: 25002117
Mitochondria, the major source of cellular energy in the form of ATP, respond to changes in substrate availability and bioenergetic demands by employing rapid, short-term, metabolic adaptation mechanisms, such as...
9.
Vullo D, Leewattanapasuk W, Muhlschlegel F, Mastrolorenzo A, Capasso C, Supuran C
Bioorg Med Chem Lett . 2013 Mar; 23(9):2647-52. PMID: 23511020
The fungal pathogen Candida glabrata encodes for a β-carbonic anhydrase (CA, EC 4.2.1.1), CgNce103, recently discovered. Only anions have been investigated as CgNce103 inhibitors up until now. Here we report...
10.
Fu M, De Sordi L, Muhlschlegel F
PLoS One . 2012 Aug; 7(8):e42894. PMID: 22880130
Hsp12p is considered to be a small heat shock protein and conserved among fungal species. To investigate the expression of this heat shock protein in the fungal pathogen Candida albicans...